This invention relates to collapsible/expandable prosthetic heart valves (especially prosthetic aortic valves) for use with non-resected calcified native valves. The prosthetic heart valve design incorporates features that hold open the native calcified leaflets away from the new valve.
In accordance with certain possible aspects of the invention, a prosthetic heart valve may utilize expansion of fork-like fingers to push calcified native leaflets out of the way. This eliminates interference with the newly deployed prosthetic valve and maximizes hemodynamic performance. It also enhances prosthetic valve frame anchoring in the patient as a result of the fingers engaging the calcified leaflets.
A prosthetic heart valve in accordance with the invention may be circumferentially collapsible and re-expandable, and may include an annular frame structure and a flexible leaflet structure disposed in the frame structure. The frame structure is preferably adapted for delivery into a patient's native heart valve annulus in a circumferentially collapsed condition. The frame structure is preferably further adapted for circumferential re-expansion when in the above-mentioned annulus. The frame structure preferably includes a leaflet restraining structure for pushing radially outwardly on a patient's native heart valve leaflet (or leaflets) when the frame structure is re-expanded. The leaflet restraining structure is preferably cantilevered from an annulus portion of the frame structure. (The annulus portion is the portion of the frame structure that re-expands in the native valve annulus.) More particularly, the leaflet restraining structure is preferably cantilevered from the annulus portion to a free end of the leaflet restraining structure that is downstream from the annulus portion in the direction of blood flow through the prosthetic valve when the prosthetic valve is in use in the patient.
The above-mentioned leaflet restraining structure may be resiliently biased to incline radially outwardly from the annulus portion as one proceeds along the restraining structure from the annulus portion toward the free end of the restraining structure.
The leaflet restraining structure may include a plurality of fingers that are spaced from one another in a direction that is circumferential around the annulus portion. Each of these fingers may be cantilevered from the annulus portion and may extend from the annulus portion in the direction of blood flow through the implanted prosthetic valve.
Each of the above-mentioned fingers may have a free end that is remote from the annulus portion. All of the fingers may extend to approximately the same distance downstream from the annulus portion in the direction of blood flow. Alternatively, a first of the fingers may extend a greater distance downstream from the annulus portion in the direction of blood flow than a second of the fingers.
The annulus portion may include two (or more) circumferentially spaced commissure regions. In such a case, and in the case of the alternative mentioned in the immediately preceding paragraph, the fingers may also be circumferentially spaced from one another between two of the commissure regions, and the above-mentioned first finger may be circumferentially closer to one of the above-mentioned two commissure regions than the above-mentioned second finger is to either of those two commissure regions.
In a case in which the leaflet restraining structure includes a plurality of fingers, the leaflet restraining structure may further include a linking structure between two circumferentially adjacent ones of the fingers. This linking structure may be downstream from the annulus portion in the direction of blood flow through the implanted prosthetic valve.
The immediately above-mentioned linking structure may be collapsible and re-expandable in a direction that is circumferential around the annulus portion.
The location of the above-mentioned linking structure may be at the ends of the linked fingers that are remote from the annulus portion.
The annulus portion may include a plurality of circumferentially spaced commissure regions, and the leaflet restraining structure may be circumferentially spaced between two circumferentially adjacent ones of those commissure regions. Especially in such a case, the leaflet restraining structure may be one of a plurality of similar leaflet restraining structures. Each of these leaflet restraining structures may be circumferentially spaced between a respective one of a plurality of pairs of circumferentially adjacent ones of the commissure regions.
The prosthetic heart valve may be an aortic valve, which may further comprise a further frame structure that includes an annular aortic portion and a plurality of struts or links between the aortic portion and the annulus portion. The aortic portion may be adapted for delivery into a patient's aorta in a circumferentially collapsed condition. The aortic portion may be further adapted to circumferentially re-expand when in the aorta. The aortic portion is preferably downstream from the free end of the leaflet restraining structure in the direction of blood flow. The above-mentioned struts or links are preferably circumferentially spaced from the leaflet restraining structure.
In cases like those mentioned in the immediately preceding paragraph, the annulus portion may include a plurality of circumferentially spaced commissure regions. The above-mentioned struts or links may then connect to the annulus portion adjacent the commissure regions. For example, the leaflet restraining structure may be circumferentially spaced between first and second circumferentially adjacent ones of the links, and the first and second links may be respectively connected to the annulus portion adjacent respective first and second circumferentially adjacent ones of the commissure regions.
Further features of the invention, its nature and various advantages, will be more apparent from the accompanying drawings and the following detailed description.
A collapsible and re-expandable prosthetic aortic valve that can self-anchor around the native commissures in the valsalva sinus is shown in Alkhatib PCT patent application No. PCT/US08/09950, filed Aug. 21, 2008, which is hereby incorporated by reference herein in its entirety. The illustrations that form part of the present disclosure are embodiments of valves like those shown in the above-mentioned reference, with the addition of leaflet retention or restraining features in accordance with this invention. It will be understood that the particular structures shown and described herein are only illustrative, and that the invention can be applied to many other prosthetic valve constructions. Some of these possible variations will be mentioned later in this specification.
Note that all of the valves shown herein may be elastically collapsible in the annular or circumferential direction to a reduced annular or circumferential size that is suitable for delivery into a patient in a less invasive way (e.g., through tube-like delivery apparatus such as a catheter, a trocar, a laparoscopic instrument, or the like). When the valve reaches the intended site for implantation, the valve may elastically re-expand to normal operating size (e.g., the size shown in
In
Recapitulating and extending the above, the following are some of the important aspects of the invention.
Features 10 (possibly with links 12) are incorporated onto a collapsible valve frame and are designed specifically to hold the native calcified leaflet back (e.g., radially outwardly) and away from the replacement valve.
Features 10 (possibly with links 12) are preferably not tall enough such that they would obstruct the coronary artery ostia.
The cantilevered leaflet retention feature typically includes several elongated, curved, fork-like fingers 10 that can be free-standing or interconnected (e.g., as shown at 12) at the distal (downstream) end.
The fingers 10 are connected to the main stent frame at their proximal (upstream) end.
The fork-like fingers 10 may be curved radially outward, away from the replacement valve.
The fork-like fingers 10 (possibly with links 12) have adequate stiffness in the radial direction to hold the calcified native valve in an open (radially outward) position.
The fork-like fingers 10 (possibly with links 12) can be scalloped (e.g.,
The fork-like fingers 10 (possibly with links 12) enhance anchoring of the prosthetic valve as a result of engaging the calcified leaflets.
While curved (radially) outward fork-like members 10 will do a good job keeping calcified leaflets out of the way, alternate designs can also be used, ranging from straight up fingers 10 to straight fingers inclined at an angle so that they are radially farther out at their free ends than where joined to annulus portion 40. Preferably, the prosthetic valve frame's geometry is designed to oppose the native leaflet once implanted and is capable of holding open, pushing outwards, engaging, and displacing the native leaflets in desired patterns to clear coronaries, and anchoring in the native leaflets. Many suitable geometries are capable of achieving these goals. The geometries can vary significantly and only some of the possible geometries are described herein.
Although the presently preferred stent structures (like 10/40/50/60) are self-expanding (i.e., elastically deformed), the present invention is equally applicable to balloon-expandable (i.e., plastically deformed) stents or a combination of self-expanding and balloon expandable (e.g., where arms like 10 are resiliently self-expanding, but the rest of the cage like 40/50/60 may be balloon-expanded). The balloon-expandable stents, which can be made of stainless steel, can be used with specifically designed balloons that have, for example, a bulbous midsection. The balloon-expendable stents can also be enlarged in two or more steps. A straight conventional balloon can be used first to anchor one or more stent structures of the valves. A second spherical balloon can then be used to specifically expand the other structure or structures such as fingers 10.
The structures like fingers 10 of this invention can also be designed to provide the following benefits. These structures preferably move the native calcified leaflets radially outwardly away from the new valve structure to avoid potential abrasion of the new valve tissue 20 against the calcified, diseased tissue. Use of this invention can provide more space for a bigger prosthetic valve and better hemodynamics. The structures like 10/12 of this invention can deform the diseased leaflets in such a way as to avoid potential coronary blockage (i.e. occlusion of the ostium of a coronary artery). The structures like 10/12 can be designed to also help with stability and anchoring of the prosthetic valve in the patient. Prior known collapsible prosthetic valves may include cages that are intended to push diseased leaflets out of the way. But these previously known structures do not attempt to control or preferentially displace the diseased leaflets in a specific configuration to provide the benefits described above for the present invention.
The attachment point of fingers 10 to the stent is described as being preferably at or near the proximal end of the prosthetic valve frame structure using the proximal end of the fingers. In another embodiment of the invention, the fingers can extend down from the distal end of stent (outflow side). Other combinations of attachment are also possible (e.g., stent inflow side and members 60 or stent outflow side and members 60).
The foregoing features can be incorporated on minimally invasive surgically implanted valves where resection of the native calcified leaflets has not been performed or is not possible.
An advantage of providing leaflet restraining structures 10/12 as structures that are cantilevered from other structure of the valve frame is that this facilitates giving the leaflet restraining structures various properties that can be relatively independent of the properties of other parts of the frame. For example, the extent to which leaflet restraining structures 10/12 incline or extend radially outwardly can be made to depend solely (or at least largely) on the design of those structures per se, and can be independent of the shape, location, etc., of other adjacent frame components such as links 60, commissure posts 42, aortic portion 50, etc. Similarly, those other portions of the valve can be designed to have properties that are independent of the properties of leaflet restraining structures 10/12. Examples of properties that can thus be designed independently for structures 10/12, on the one hand, and other portions of the frame, on the other hand, include (1) collapsed location (i.e., location during delivery), (2) re-expanded location (i.e., location when deployed and implanted in the patient), (3) size, (4) shape, (5) stiffness, (6) strength, (7) resilience, etc.
It will be understood that the foregoing is only illustrative of the principles of the invention, and that various modifications can be made by those skilled in the art without departing from the scope and spirit of the invention. For example, the number of leaflet restraining structures that are provided can be more or less than the number shown herein.
This application is a continuation application of U.S. application Ser. No. 14/824,209, filed Aug. 12, 2015, which is a continuation application of U.S. application Ser. No. 14/280,868, filed May 19, 2014 which is a continuation application of U.S. application Ser. No. 12/733,763, filed Mar. 18, 2010, which is a national phase entry under 35 U.S.C. §371 of International Application No. PCT/US2008/11181, filed Sep. 26, 2008, published in English, which claims the benefit of U.S. Provisional Patent Application No. 60/995,845, filed Sep. 28, 2007, the disclosures of all of which are hereby incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
3657744 | Ersek | Apr 1972 | A |
4192020 | Davis et al. | Mar 1980 | A |
4275469 | Gabbay | Jun 1981 | A |
4340091 | Skelton et al. | Jul 1982 | A |
4423730 | Gabbay | Jan 1984 | A |
4491986 | Gabbay | Jan 1985 | A |
4731074 | Rousseau et al. | Mar 1988 | A |
4759758 | Gabbay | Jul 1988 | A |
4878906 | Lindemann et al. | Nov 1989 | A |
4922905 | Strecker | May 1990 | A |
4994077 | Dobben | Feb 1991 | A |
5411552 | Andersen et al. | May 1995 | A |
5480423 | Ravenscroft et al. | Jan 1996 | A |
5843167 | Dwyer et al. | Dec 1998 | A |
5855601 | Bessler et al. | Jan 1999 | A |
5924424 | Stevens et al. | Jul 1999 | A |
5935163 | Gabbay | Aug 1999 | A |
5961549 | Nguyen et al. | Oct 1999 | A |
5968068 | Dehdashtian et al. | Oct 1999 | A |
6077297 | Robinson et al. | Jun 2000 | A |
6083257 | Taylor et al. | Jul 2000 | A |
6090140 | Gabbay | Jul 2000 | A |
6168614 | Andersen et al. | Jan 2001 | B1 |
6214036 | Letendre et al. | Apr 2001 | B1 |
6264691 | Gabbay | Jul 2001 | B1 |
6267783 | Letendre et al. | Jul 2001 | B1 |
6306141 | Jervis | Oct 2001 | B1 |
6312465 | Griffin et al. | Nov 2001 | B1 |
6358277 | Duran | Mar 2002 | B1 |
6368348 | Gabbay | Apr 2002 | B1 |
6419695 | Gabbay | Jul 2002 | B1 |
6425916 | Garrison et al. | Jul 2002 | B1 |
6454799 | Schreck | Sep 2002 | B1 |
6468660 | Ogle et al. | Oct 2002 | B2 |
6488702 | Besselink | Dec 2002 | B1 |
6517576 | Gabbay | Feb 2003 | B2 |
6533810 | Hankh et al. | Mar 2003 | B2 |
6582464 | Gabbay | Jun 2003 | B2 |
6610088 | Gabbay | Aug 2003 | B1 |
6623518 | Thompson et al. | Sep 2003 | B2 |
6685625 | Gabbay | Feb 2004 | B2 |
6719789 | Cox | Apr 2004 | B2 |
6726715 | Sutherland | Apr 2004 | B2 |
6730118 | Spenser et al. | May 2004 | B2 |
6733525 | Yang et al. | May 2004 | B2 |
6767362 | Schreck | Jul 2004 | B2 |
6783556 | Gabbay | Aug 2004 | B1 |
6790230 | Beyersdorf et al. | Sep 2004 | B2 |
6814746 | Thompson et al. | Nov 2004 | B2 |
6830584 | Seguin | Dec 2004 | B1 |
6830585 | Artof et al. | Dec 2004 | B1 |
6869444 | Gabbay | Mar 2005 | B2 |
6875231 | Anduiza et al. | Apr 2005 | B2 |
6893460 | Spenser et al. | May 2005 | B2 |
6908481 | Cribier | Jun 2005 | B2 |
6916338 | Speziali | Jul 2005 | B2 |
7018406 | Seguin | Mar 2006 | B2 |
7025780 | Gabbay | Apr 2006 | B2 |
7041132 | Quijano et al. | May 2006 | B2 |
7044966 | Svanidze et al. | May 2006 | B2 |
7101396 | Artof et al. | Sep 2006 | B2 |
7137184 | Schreck | Nov 2006 | B2 |
7160322 | Gabbay | Jan 2007 | B2 |
7247167 | Gabbay | Jul 2007 | B2 |
7267686 | DiMatteo et al. | Sep 2007 | B2 |
7311730 | Gabbay | Dec 2007 | B2 |
7329278 | Seguin et al. | Feb 2008 | B2 |
7331993 | White | Feb 2008 | B2 |
7374573 | Gabbay | May 2008 | B2 |
7381218 | Schreck | Jun 2008 | B2 |
7452371 | Pavcnik et al. | Nov 2008 | B2 |
7510572 | Gabbay | Mar 2009 | B2 |
7524331 | Birdsall | Apr 2009 | B2 |
RE40816 | Taylor et al. | Jun 2009 | E |
7585321 | Cribier | Sep 2009 | B2 |
7682390 | Seguin | Mar 2010 | B2 |
7708775 | Rowe | May 2010 | B2 |
7731742 | Schlick et al. | Jun 2010 | B2 |
7799072 | Greenberg | Sep 2010 | B2 |
7803185 | Gabbay | Sep 2010 | B2 |
7846203 | Cribier | Dec 2010 | B2 |
7846204 | Letac et al. | Dec 2010 | B2 |
7871436 | Ryan et al. | Jan 2011 | B2 |
7914569 | Nguyen et al. | Mar 2011 | B2 |
D648854 | Braido | Nov 2011 | S |
D652926 | Braido | Jan 2012 | S |
D652927 | Braido et al. | Jan 2012 | S |
D653341 | Braido et al. | Jan 2012 | S |
D653342 | Braido et al. | Jan 2012 | S |
D653343 | Ness et al. | Jan 2012 | S |
D654169 | Braido | Feb 2012 | S |
D654170 | Braido et al. | Feb 2012 | S |
D660432 | Braido | May 2012 | S |
D660433 | Braido et al. | May 2012 | S |
D660967 | Braido et al. | May 2012 | S |
8444689 | Zhang | May 2013 | B2 |
D684692 | Braido | Jun 2013 | S |
8454686 | Alkhatib | Jun 2013 | B2 |
8465540 | Straubinger et al. | Jun 2013 | B2 |
8597349 | Alkhatib | Dec 2013 | B2 |
8728154 | Alkhatib | May 2014 | B2 |
8784481 | Alkhatib et al. | Jul 2014 | B2 |
8808366 | Braido et al. | Aug 2014 | B2 |
8882831 | Alkhatib | Nov 2014 | B2 |
8961595 | Alkhatib | Feb 2015 | B2 |
9364321 | Alkhatib | Jun 2016 | B2 |
20020036220 | Gabbay | Mar 2002 | A1 |
20030023303 | Palmaz et al. | Jan 2003 | A1 |
20030050694 | Yang et al. | Mar 2003 | A1 |
20030055495 | Pease et al. | Mar 2003 | A1 |
20030055496 | Cai et al. | Mar 2003 | A1 |
20030130726 | Thorpe et al. | Jul 2003 | A1 |
20030153974 | Spenser et al. | Aug 2003 | A1 |
20030153975 | Byrd et al. | Aug 2003 | A1 |
20040039436 | Spenser et al. | Feb 2004 | A1 |
20040049262 | Obermiller et al. | Mar 2004 | A1 |
20040088046 | Speziali | May 2004 | A1 |
20040093060 | Seguin et al. | May 2004 | A1 |
20040093075 | Kuehne | May 2004 | A1 |
20040186563 | Lobbi | Sep 2004 | A1 |
20040186565 | Schreck | Sep 2004 | A1 |
20040210304 | Seguin et al. | Oct 2004 | A1 |
20050096726 | Sequin et al. | May 2005 | A1 |
20050137695 | Salahieh et al. | Jun 2005 | A1 |
20050137697 | Salahieh et al. | Jun 2005 | A1 |
20050177227 | Heim et al. | Aug 2005 | A1 |
20050192665 | Spenser et al. | Sep 2005 | A1 |
20050197695 | Stacchino et al. | Sep 2005 | A1 |
20050209689 | Speziali | Sep 2005 | A1 |
20050256566 | Gabbay | Nov 2005 | A1 |
20060008497 | Gabbay | Jan 2006 | A1 |
20060074484 | Huber | Apr 2006 | A1 |
20060106415 | Gabbay | May 2006 | A1 |
20060122692 | Gilad et al. | Jun 2006 | A1 |
20060142848 | Gabbay | Jun 2006 | A1 |
20060149360 | Schwammenthal et al. | Jul 2006 | A1 |
20060167468 | Gabbay | Jul 2006 | A1 |
20060173532 | Flagle et al. | Aug 2006 | A1 |
20060178740 | Stacchino et al. | Aug 2006 | A1 |
20060190074 | Hill et al. | Aug 2006 | A1 |
20060206202 | Bonhoeffer et al. | Sep 2006 | A1 |
20060241744 | Beith | Oct 2006 | A1 |
20060241745 | Solem | Oct 2006 | A1 |
20060259120 | Vongphakdy et al. | Nov 2006 | A1 |
20060259136 | Nguyen et al. | Nov 2006 | A1 |
20060259137 | Artof et al. | Nov 2006 | A1 |
20060265056 | Nguyen et al. | Nov 2006 | A1 |
20060276813 | Greenberg | Dec 2006 | A1 |
20070010876 | Salahieh et al. | Jan 2007 | A1 |
20070027534 | Bergheim et al. | Feb 2007 | A1 |
20070043435 | Seguin et al. | Feb 2007 | A1 |
20070055358 | Krolik et al. | Mar 2007 | A1 |
20070067029 | Gabbay | Mar 2007 | A1 |
20070073391 | Bourang et al. | Mar 2007 | A1 |
20070088431 | Bourang et al. | Apr 2007 | A1 |
20070093890 | Eliasen et al. | Apr 2007 | A1 |
20070100435 | Case et al. | May 2007 | A1 |
20070112422 | Dehdashtian | May 2007 | A1 |
20070118210 | Pinchuk | May 2007 | A1 |
20070162100 | Gabbay | Jul 2007 | A1 |
20070168013 | Douglas | Jul 2007 | A1 |
20070203575 | Forster et al. | Aug 2007 | A1 |
20070213813 | Von Segesser et al. | Sep 2007 | A1 |
20070233228 | Eberhardt et al. | Oct 2007 | A1 |
20070239271 | Nguyen | Oct 2007 | A1 |
20070244545 | Birdsall et al. | Oct 2007 | A1 |
20070244552 | Salahieh et al. | Oct 2007 | A1 |
20070282436 | Pinchuk | Dec 2007 | A1 |
20070288087 | Fearnot et al. | Dec 2007 | A1 |
20080021552 | Gabbay | Jan 2008 | A1 |
20080039934 | Styrc | Feb 2008 | A1 |
20080071368 | Tuval et al. | Mar 2008 | A1 |
20080071369 | Tuval et al. | Mar 2008 | A1 |
20080082164 | Friedman | Apr 2008 | A1 |
20080097595 | Gabbay | Apr 2008 | A1 |
20080114452 | Gabbay | May 2008 | A1 |
20080125853 | Bailey et al. | May 2008 | A1 |
20080140189 | Nguyen et al. | Jun 2008 | A1 |
20080147179 | Cai et al. | Jun 2008 | A1 |
20080147182 | Righini et al. | Jun 2008 | A1 |
20080147183 | Styrc | Jun 2008 | A1 |
20080154355 | Benichou et al. | Jun 2008 | A1 |
20080154356 | Obermiller et al. | Jun 2008 | A1 |
20080228263 | Ryan | Sep 2008 | A1 |
20080228264 | Li et al. | Sep 2008 | A1 |
20080243245 | Thambar et al. | Oct 2008 | A1 |
20080243246 | Ryan et al. | Oct 2008 | A1 |
20080255662 | Stacchino et al. | Oct 2008 | A1 |
20080262602 | Wilk et al. | Oct 2008 | A1 |
20080269879 | Sathe et al. | Oct 2008 | A1 |
20090054975 | del Nido et al. | Feb 2009 | A1 |
20090082858 | Nugent | Mar 2009 | A1 |
20090112309 | Jaramillo et al. | Apr 2009 | A1 |
20090138079 | Tuval et al. | May 2009 | A1 |
20100004740 | Seguin et al. | Jan 2010 | A1 |
20100036484 | Hariton et al. | Feb 2010 | A1 |
20100036485 | Seguin | Feb 2010 | A1 |
20100049306 | House et al. | Feb 2010 | A1 |
20100087907 | Lattouf | Apr 2010 | A1 |
20100114307 | Agnew et al. | May 2010 | A1 |
20100131054 | Tuval et al. | May 2010 | A1 |
20100131055 | Case et al. | May 2010 | A1 |
20100168778 | Braido | Jul 2010 | A1 |
20100168839 | Braido et al. | Jul 2010 | A1 |
20100185277 | Braido et al. | Jul 2010 | A1 |
20100191326 | Alkhatib | Jul 2010 | A1 |
20100204781 | Alkhatib | Aug 2010 | A1 |
20100204785 | Alkhatib | Aug 2010 | A1 |
20100217382 | Chau et al. | Aug 2010 | A1 |
20100249911 | Alkhatib | Sep 2010 | A1 |
20100249923 | Alkhatib et al. | Sep 2010 | A1 |
20100286768 | Alkhatib | Nov 2010 | A1 |
20100298931 | Quadri et al. | Nov 2010 | A1 |
20110029072 | Gabbay | Feb 2011 | A1 |
20110082539 | Suri | Apr 2011 | A1 |
20110224678 | Gabbay | Sep 2011 | A1 |
20120078347 | Braido et al. | Mar 2012 | A1 |
20130245753 | Alkhatib | Sep 2013 | A1 |
20140236289 | Alkhatib | Aug 2014 | A1 |
20140296966 | Braido et al. | Oct 2014 | A1 |
20150032206 | Alkhatib | Jan 2015 | A1 |
Number | Date | Country |
---|---|---|
19857887 | Jul 2000 | DE |
10121210 | Nov 2002 | DE |
202008009610 | Dec 2008 | DE |
0331345 | Sep 1989 | EP |
0850607 | Jul 1998 | EP |
1000590 | May 2000 | EP |
1129744 | Sep 2001 | EP |
1157673 | Nov 2001 | EP |
1360942 | Nov 2003 | EP |
1584306 | Oct 2005 | EP |
1598031 | Nov 2005 | EP |
1926455 | Jun 2008 | EP |
2847800 | Jun 2004 | FR |
2850008 | Jul 2004 | FR |
9117720 | Nov 1991 | WO |
9716133 | May 1997 | WO |
9832412 | Jul 1998 | WO |
9913801 | Mar 1999 | WO |
0128459 | Apr 2001 | WO |
0149213 | Jul 2001 | WO |
0154625 | Aug 2001 | WO |
0156500 | Aug 2001 | WO |
0176510 | Oct 2001 | WO |
0236048 | May 2002 | WO |
0247575 | Jun 2002 | WO |
03047468 | Jun 2003 | WO |
2004047619 | Jun 2004 | WO |
2006073626 | Jul 2006 | WO |
2007013999 | Feb 2007 | WO |
2007053243 | May 2007 | WO |
2007071436 | Jun 2007 | WO |
2008070797 | Jun 2008 | WO |
2009029199 | Mar 2009 | WO |
2009042196 | Apr 2009 | WO |
2009045332 | Apr 2009 | WO |
2009045334 | Apr 2009 | WO |
2010008548 | Jan 2010 | WO |
2010008549 | Jan 2010 | WO |
2010051025 | May 2010 | WO |
2010087975 | Aug 2010 | WO |
2010096176 | Aug 2010 | WO |
2010098857 | Sep 2010 | WO |
2013075215 | May 2013 | WO |
Entry |
---|
PCT International Search Report for Application No. PCT/US2008/011153 dated Jan. 26, 2009. |
U.S. Appl. No. 29/375,232. |
U.S. Appl. No. 29/375,235. |
U.S. Appl. No. 29/375,238. |
U.S. Appl. No. 29/375,239. |
U.S. Appl. No. 29/375,245. |
U.S. Appl. No. 29/375,251. |
U.S. Appl. No. 29/375,252. |
U.S. Appl. No. 29/375,253. |
U.S. Appl. No. 29/375,254. |
U.S. Appl. No. 29/375,257. |
U.S. Appl. No. 29/375,258. |
U.S. Appl. No. 29/375,260. |
International Search Report for Application No. PCT/US2008/011181 dated Feb. 18, 2009. |
Design U.S. Appl. No. 29/375,243, filed Sep. 20, 2010. |
Ruiz, Carlos, “Overview of PRE-CE Mark Transcatheter Aortic Valve Technologies”, Euro PCR, May 25, 2010. |
Quaden, René et al., “Percutaneous aortic valve replacement: resection before implantation,” 836-840, European J. of Cardio-thoracic Surgery 27 (2005). |
Knudsen, L.L. et al., Catheter-implanted prosthetic heart valves, The International Journal of Artificial Organs, vol. 16, No. 5 1993, pp. 253-262. |
Transluminal Aortic Valve Placement, Moazami, Nader, et al., ASAIO Journal, 1996; 42:M381-M385. |
Andersen, Henning Rud, Transluminal Catheter Implanted Prosthetic Heart Valves, International Journal of Angiology 7:102-106 (1998). |
Andersen, H. R. et al, Transluminal implantation of artificial heart valves, European Heart Journal (1992) 13, 704-708. |
Zegdi, Rachid, MD, PhD et al., “Is It Reasonable to Treat All Calcified Stenotic Aortic Valves With a Valved Stent?” 579-584, J. of the American College of Cardiology, vol. 51, No. 5, Feb. 5, 2008. |
Number | Date | Country | |
---|---|---|---|
20150374490 A1 | Dec 2015 | US |
Number | Date | Country | |
---|---|---|---|
60995845 | Sep 2007 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14824209 | Aug 2015 | US |
Child | 14850018 | US | |
Parent | 14280868 | May 2014 | US |
Child | 14824209 | US | |
Parent | 12733763 | US | |
Child | 14280868 | US |